Citadel Advisors - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$5,727
-76.8%
30,140
-58.5%
0.00%
Q1 2023$24,720
-16.7%
72,706
-27.3%
0.00%
Q4 2022$29,690
-4.2%
99,964
+300.8%
0.00%
Q1 2022$31,000
-45.6%
24,940
-10.6%
0.00%
Q3 2021$57,000
+185.0%
27,900
+118.0%
0.00%
Q2 2021$20,000
-42.9%
12,800
-17.9%
0.00%
Q1 2021$35,000
-78.4%
15,600
-65.9%
0.00%
Q2 2020$162,000
+260.0%
45,691
+139.2%
0.00%
Q1 2020$45,000
-28.6%
19,100
-33.5%
0.00%
Q4 2019$63,000
+43.2%
28,706
+19.8%
0.00%
Q3 2019$44,000
+2.3%
23,963
-19.6%
0.00%
Q2 2019$43,000
-65.3%
29,800
-52.9%
0.00%
Q1 2019$124,000
+85.1%
63,244
+23.4%
0.00%
Q4 2018$67,000
-58.1%
51,258
-21.3%
0.00%
Q3 2018$160,000
-41.0%
65,166
-19.0%
0.00%
Q2 2018$271,000
+129.7%
80,425
+189.1%
0.00%
Q1 2018$118,000
+73.5%
27,821
+35.1%
0.00%
Q4 2017$68,000
-45.2%
20,600
-36.1%
0.00%
Q3 2017$124,000
-52.5%
32,246
-45.6%
0.00%
Q2 2017$261,000
-30.2%
59,300
-42.6%
0.00%
Q1 2017$374,000
+77.3%
103,263
+30.9%
0.00%
Q4 2016$211,000
-30.4%
78,900
-15.1%
0.00%
Q3 2016$303,00092,9610.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders